Treatment Option Response Time Key to Patients Emotional Well Being – Presented at San Antonio Breast Cancer Symposium (SABCS) – December 6-7, 2018
CAMBRIDGE, Mass. and SAN ANTONIO, Texas and Mumbai, INDIA – Dec. 6, 2018 – Navya, a clinical informatics and cancer patient services company, founded by graduates of Harvard, MIT Sloan and Stanford in conjunction with Tata Memorial Centre (TMC) and National Cancer Grid (NCG), has been invited to present this impactful study at the 2018 San Antonio Breast Cancer Symposium (SABCS).
Dr. Naresh Ramarajan, Navya’s Chief Medical Officer, will be presenting, “Responding at patient’s time of need: Scaling rapid access to evidence based treatment plan” Thursday, December 6, 2018, 5-7pm. Program Number: P3-16-01at this years SABCS. This presentation focuses on a study that reveals providing preliminary reports with treatment recommendations within one day of testing relieves patient anxiety by over 97 percent.
Navya’s patented system uses clinical informatics, predictive analytics and machine learning. These technologies, which were validated with clinical experts and presented at SABCS 2014, provide patients an upper hand to assess a cancer care decision for themselves, while making available an easy, quick, and preliminary treatment decision pathway, based on an evidence and experience based system, thereby relieving patient anxiety.
Dr. Naresh Ramarajan said, “System based preliminary reports sent to the patient at a median time of 3.37 hours has proven beneficial, resulting in a 90 percent time savings in comparison to subsequent review by experts. In 10 percent of the preliminary reports, experts added information such as de-/escalating treatment, and additional diagnostic tests.”
Analyzing impact on patients, Dr. Ramarajan added: “Providing preliminary reports with a treatment recommendation within one day, relieves patient anxiety by over 97 percent. However, even a one day delay, increases patient anxiety by over 15 percent. Therefore, each day in waiting matters.”
About Dr. Naresh Ramarajan
Dr. Naresh Ramarajan is an American board certified internist and emergency physician. His research is in medical decision making and clinical informatics, in which he is also board certified. Dr. Ramarajan is the founder of Navya, an organization that empowers cancer patients and oncologists around the world with on-time access to evidence and experience based expertise.
About Tata Memorial Centre
Tata Memorial Centre, founded in 1941, leads the Indian subcontinent in cancer care by evidence based practice of oncology, and research and services which are affordable, innovative, and relevant to the needs of the country. Every year nearly 10 million patients visit TMC from all over India and developing countries in Asia, Africa. Approximately, 70 percent of these patients are treated almost free of charge. Visit: https://tmc.gov.in.
In 2009, Navya was founded in Cambridge, MA by graduates of Harvard, MIT Sloan, and Stanford. Navya’s patented system uses clinical informatics, predictive analytics and machine learning technologies. It combines several clinical information sources as inputs – and outputs a treatment decision most applicable to a unique patient. For the first time, quick and affordable access to evidence and experience based expert treatment decisions is available to every cancer patient. Navya’s Online Expert Opinion Service has been used by over 26,000 patients in 67 countries.
Visit: Navya Online Navya Twitter Navya Facebook Navya LinkedIn
All trademarks recognized.